Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LOCKHART

Showing results (381-390 of 454) with videos related to

Pageof 46
Sort By:
Orphanet Journal of Rare Diseases|March 29, 2014
Expanding the phenotypic spectrum of ARID1B-mediated disorders and identification of altered cell-cycle dynamics due to ARID1B haploinsufficiencyJoe C H Sim, Susan M White, Elizabeth Fitzpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
Inhaled <i>DNAI1</i> mRNA therapy for treatment of primary ciliary dyskinesiaMirko Hennig, Rumpa B Bhattacharjee, Ishita Agarwal, et al.
Plos One|August 8, 2015
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused AgalsidaseDavid G Warnock, Daniel G Bichet, Myrl Holida, et al.
Neurology. Genetics|May 5, 2018
Somatic <i>GNAQ</i> mutation in the <i>forme fruste</i> of Sturge-Weber syndromeMichael S Hildebrand, A Simon Harvey, Stephen Malone, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5Thomas Scerri, Jessica R Riseley, Greta Gillies, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastatElfrida R Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, et al.
European Heart Journal|April 24, 2016
ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathyDean G Phelan, David J Anderson, Sara E Howden, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2004
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2)Sarah Furtado, Haydeh Payami, Paul J Lockhart, et al.
Annals of Neurology|August 19, 2015
Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3Joe C Sim, Thomas Scerri, Miriam Fanjul-Fernández, et al.
Elife|April 19, 2021
DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formationLaura Morcom, Ilan Gobius, Ashley Pl Marsh, et al.
Pageof 46

Showing results (381-390 of 454) with videos related to

Sort By:
Pageof 46
Orphanet Journal of Rare Diseases|March 29, 2014
Expanding the phenotypic spectrum of ARID1B-mediated disorders and identification of altered cell-cycle dynamics due to ARID1B haploinsufficiencyJoe C H Sim, Susan M White, Elizabeth Fitzpatrick, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2025
Inhaled <i>DNAI1</i> mRNA therapy for treatment of primary ciliary dyskinesiaMirko Hennig, Rumpa B Bhattacharjee, Ishita Agarwal, et al.
Plos One|August 8, 2015
Oral Migalastat HCl Leads to Greater Systemic Exposure and Tissue Levels of Active α-Galactosidase A in Fabry Patients when Co-Administered with Infused AgalsidaseDavid G Warnock, Daniel G Bichet, Myrl Holida, et al.
Neurology. Genetics|May 5, 2018
Somatic <i>GNAQ</i> mutation in the <i>forme fruste</i> of Sturge-Weber syndromeMichael S Hildebrand, A Simon Harvey, Stephen Malone, et al.
Annals of Clinical and Translational Neurology|May 23, 2015
Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC5Thomas Scerri, Jessica R Riseley, Greta Gillies, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastatElfrida R Benjamin, Maria Cecilia Della Valle, Xiaoyang Wu, et al.
European Heart Journal|April 24, 2016
ALPK3-deficient cardiomyocytes generated from patient-derived induced pluripotent stem cells and mutant human embryonic stem cells display abnormal calcium handling and establish that ALPK3 deficiency underlies familial cardiomyopathyDean G Phelan, David J Anderson, Sara E Howden, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 16, 2004
Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2)Sarah Furtado, Haydeh Payami, Paul J Lockhart, et al.
Annals of Neurology|August 19, 2015
Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3Joe C Sim, Thomas Scerri, Miriam Fanjul-Fernández, et al.
Elife|April 19, 2021
DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formationLaura Morcom, Ilan Gobius, Ashley Pl Marsh, et al.
Pageof 46